FWWNX | ODVCX | FWWNX / ODVCX | |
Total Expense Ratio | 0.63 | 2.03 | 31% |
Annual Report Gross Expense Ratio | 0.63 | 2.03 | 31% |
Fund Existence | 5 years | 29 years | - |
Gain YTD | 16.243 | 11.649 | 139% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 70.1B | 14B | 501% |
Annual Yield % from dividends | 1.04 | 0.00 | - |
Returns for 1 year | 11.46 | 4.99 | 230% |
Returns for 3 years | 43.03 | 22.25 | 193% |
Returns for 5 years | N/A | -4.64 | - |
Returns for 10 years | N/A | 17.59 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XPH | 42.62 | 0.35 | +0.83% |
SPDR® S&P Pharmaceuticals ETF | |||
AMDG | 20.47 | 0.10 | +0.49% |
Leverage Shares 2X Long AMD Daily ETF | |||
IBB | 131.74 | 0.56 | +0.43% |
iShares Biotechnology ETF | |||
ZALT | 31.08 | 0.06 | +0.19% |
Innovator U.S. Equity 10 Buffr ETF - Qt | |||
AAPB | 21.04 | 0.02 | +0.10% |
GraniteShares 2x Long AAPL Daily ETF |